Company profile
Non-Invasive Healthcare | cfDNA Products | Nonacus
Non-Invasive Healthcare - Helping genomic healthcare professionals and researchers improve patient care through validated cell-free DNA solutions.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
PARENT_ACC | Transaction MzQzOTMzMTA3MmFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 12:19
AGREEMENT2 | Transaction MzQzOTMzMTA1OWFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 11:49
AA | Transaction MzQzOTMzMTIyNWFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 11:39
GUARANTEE2 | Transaction MzQzOTMzMDk2MWFkaXF6a2N4 | Paper/PDF filed
Published 18 Oct 2024 11:39
Company registered at Companies House
9 Apr 2026 to 9 Apr 2029
GALEAS Bladder is a simple, non-invasive urine test to detect the presence of bladder cancer. Developed in partnership with researchers at the University of Birmingham, UK, the test leverages ultra-sensitive targeted Next Generation Sequencing (NGS) to interrogate the key somatic mutations found across all grades and stages of bladder cancer. This project...
1 Jun 2020 to 30 Nov 2020
The current COVID-19 pandemic requires advanced diagnostics assays which can be rapidly deployed across many laboratories, globally and to allow for both diagnostic COVID-19 testing but additionally a for surveillance and monitoring of the disease within and between populations by public health institutions. To date ourselves and others have developed and...
